RxDoctor Payments Data

Joseph Lacy

Neurology · Palo Alto, CANPI 1568570166

Payments from drug & device makers

$110,028in general payments, 2019–2025

Across 184 payments — averaging $597.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$41K
  • Genentech, Inc.$24K
  • Sanofi$21K
  • EMD Serono, Inc.$11K
  • Novartis$7K
  • E.r. Squibb & Sons, L.L.C.$4K
  • plus $2K from 5 others

What the payments were for

  • Consulting fees$22,63326%
  • Speaking & faculty fees$51,58660%
  • Travel & lodging$7,0978%
  • Food & beverage$4,7476%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen28$41,435
Genentech, Inc.17$23,965
Sanofi28$21,102
EMD Serono, Inc.60$11,042
Novartis14$6,698
E.r. Squibb & Sons, L.L.C.2$3,706
Bristol Myers Squibb6$1,065
AbbVie(2 entities)20$466
AstraZeneca5$399
Amgen(2 entities)3$131
Acadia Pharmaceuticals Inc1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$110,028 in reported general payments places this provider in the 85th percentile of 1,996 neurology providers in California.

See all neurology providers in California

Other neurology in Palo Alto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →